[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Veracyte, Inc. (VCYT)
Morgan Stanley raises Veracyte target to $XX from $40, while Canaccord Genuity initiates coverage with a Hold rating and $XX price target.
About Veracyte, Inc.
Veracyte, Inc. is a healthcare company specializing in AI-driven diagnostics.
Veracyte, Inc. uses the ticker $VCYT for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Veracyte, Inc. (VCYT) trading volume is up XXXXX% from the previous week.
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
The stock price is near its 52-week high, supported by positive social media engagement and recent research developments, though it faces headwinds from negative market sentiment and a prior downgrade.
24-Hour: -XXXX% 7-Day: -XXXXX% 30-Day: -XXXX%
1-Year High: $XXXXX on 2025-11-25
1-Year Low: $XX on 2025-07-21
AltRank: XXXXX
AltRank 24-Hour Time-Series Raw Data
Veracyte, Inc. (VCYT) is currently AltRank #1,473 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXXXX +519
X Month: XXXXX +258
X Months: XXXXX +809
X Year: XXXXX +881
1-Year High: XXXXX on 2025-09-24
1-Year Low: XX on 2025-03-08
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
X Month: XX -XX
X Months: XX -X
X Year: XX -XX
1-Year High: XX on 2025-11-05
1-Year Low: X on 2025-12-09
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXX -XXXX%
X Months: XXXXXXX +22%
X Year: XXXXXXX +35%
1-Year High: XXXXXX on 2025-07-11
1-Year Low: X on 2025-10-12
Engagements by network (24h): Reddit: X TikTok: XX X: XX YouTube: XX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX +75%
X Months: XXXXX +84%
X Year: XXXXX +112%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-10-12
Mentions by network (24h): Reddit: X TikTok: X X: XX YouTube: X
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Veracyte, Inc. (VCYT) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX +59%
X Months: XXXXX +228%
X Year: XXXXX +197%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-10-12
The most influential creators that mention Veracyte, Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @seedytx19 | X | XXXXX | X | X |
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XXX% no change
X Months: XXX% no change
X Year: XXX% +42%
1-Year High: XXX% on 2025-01-15
1-Year Low: XX% on 2025-03-14
Most Supportive Themes:
- Afirma GRID Research Tool: (30%) Veracyte's new Afirma GRID research tool is being highlighted for its potential to advance thyroid nodule testing.
- Prostate Cancer Biomarker Research: (25%) Veracyte is involved in groundbreaking research using the Decipher GRID-enabled biomarker PAM50 to predict hormone therapy benefit in prostate cancer.
- Affordable Growth Selection: (15%) Veracyte is identified as a top affordable growth stock by ChartMill, indicating positive investor interest.
Most Critical Themes:
- Negative Market Sentiment and Downgrade: (70%) Despite increased social engagement, Veracyte's stock price is near its 52-week low due to negative market sentiment and a recent downgrade.
Social Dominance: XXXXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXXXX%
X Week: XXXXXX% -XXXXXX%
X Month: XXXXX% +0.0032%
X Months: XXXXX% +0.0042%
X Year: XXXXX% -XXXXXX%
1-Year High: XXXX% on 2025-01-02
1-Year Low: XXXXXX% on 2025-10-12
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-01-09
1-Year Low: XXXXXXX% on 2025-07-21
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX -$10%
X Month: $XXXXXXXXXXXXX -$0.42%
X Months: $XXXXXXXXXXXXX +$62%
X Year: $XXXXXXXXXXXXX -$0.42%
1-Year High: $XXXXXXXXXXXXX on 2025-11-25
1-Year Low: $XXXXXXXXXXXXX on 2025-07-21
Top Veracyte, Inc. Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Buy Signal Veracyte Inc - XX Dec 2025 @ 11:06 - USD42.36"
Reddit Link @jvc72 2025-12-11T16:14Z X followers, X engagements
"Pre-Market Midcaps ($2-20B) - Dec X Gainers Losers $WVE +68% $FLNC -XXX% $KYMR +34% $LCID -XXX% $GPCR +31% $CHA -XXX% $CFLT +29% $PBF -XXX% $NRIX +16% $TTAM -XXX% $OCUL +15% $VCYT -XXX% $ARWR +12% $ESTA -XXX% $COGT +11% $LIF -XXX% $RARE +8.3% $UGP -XXX% $PRIM +8.1% $WSHP -XXX% $INDV +8% $CRK -XXX% $ACLX +7.3% $ENTG -XXX% $DYN +6.3% $IFF -X% $RXRX +5.7% $RRC -X% $TERN +5.6% $ENLT -2%"
X Link @MarketCap_Live 2025-12-08T14:56Z XXX followers, XXX engagements
"Pre-Market Movers December X Top Gainers (Pre-Market) $KYMR Kymera Therapeutics +39.9% $GPCR Structure Therapeutics +30.2% $CFLT Confluent +29.4% $OCUL Ocular Therapeutix +18.0% $ACLX Arcellx +12.1% Top Losers (Pre-Market) $MRVL Marvell Technology -XXX% $UL Unilever -XXX% $VCYT Veracyte -XXX% $MEOH Methanex -XXX% $CRVW CoreWeave -4.6%"
X Link @allday_stocks 2025-12-08T14:10Z 2309 followers, XXX engagements
"Artisan US Mid Cap Growth Strategy on Veracyte $VCYT US Thesis: Veracyte is a molecular diagnostics company that enables noninvasive cancer testing leading to significant revenue growth and expansion of its product offerings. (From their Q325 letter link in bio)"
X Link @StockCompil 2025-12-06T20:30Z 9362 followers, 1190 engagements